If you missed out of the great #NephJC chat this week you can catch-up with our rapid 10 tweet summary.
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
If you missed out of the great #NephJC chat this week you can catch-up with our rapid 10 tweet summary.
Welcome to #TenTweetNephJC
— Nephrology Jrnl Club (@NephJC) August 3, 2022
To salt or not to salt? 🧂 That is the question in heart failure💔
✳️ 10 tweets #NephJC catch-up ✳️
Missed the SODIUM-HF trial discussed last week? Read on for a snapshot of this RCT of dietary sodium reduction in patients with heart failure! pic.twitter.com/mk5D8YAvwF